Bio-Rad Laboratories (BIO) reported fourth quarter net income of $1.65 per share after the close Tuesday, down from $2.08 per share last year. The consensus estimate was for EPS of $1.34.
Bio-Rad Laboratories spiked to the upside in early trade Wednesday, but settled into a range for the majority of the session. Shares finished up by 6.25 at $123.55. The stock surged to a new high for the year on the highest volume in 2 months.
For comments and feedback: editorial@rttnews.com